Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-18

FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. The approval updates the labeling to reflect the appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)

Snippet

SUPPL AP for EPIVIR (LAMIVUDINE)